Your browser doesn't support javascript.
loading
How Does the Addition of Kollidon®VA64 Inhibit the Recrystallization and Improve Ezetimibe Dissolution from Amorphous Solid Dispersions?
Szafraniec-Szczesny, Joanna; Antosik-Rogóz, Agata; Kurek, Mateusz; Gawlak, Karolina; Górska, Anna; Peralta, Sebastian; Knapik-Kowalczuk, Justyna; Kramarczyk, Daniel; Paluch, Marian; Jachowicz, Renata.
Afiliação
  • Szafraniec-Szczesny J; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.
  • Antosik-Rogóz A; Department of Physical Chemistry and Electrochemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.
  • Kurek M; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.
  • Gawlak K; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.
  • Górska A; Department of Physical Chemistry and Electrochemistry, Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.
  • Peralta S; Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland.
  • Knapik-Kowalczuk J; Pharmacy and Pharmaceutical Technology Department, School of Pharmacy, University of Granada, Campus de Cartuja s/n., 18071 Granada, Spain.
  • Kramarczyk D; Faculty of Science and Technology, Institute of Physics and SMCEBI, University of Silesia, 75 Pulku Piechoty 1a, 41-500 Chorzów, Poland.
  • Paluch M; Faculty of Science and Technology, Institute of Physics and SMCEBI, University of Silesia, 75 Pulku Piechoty 1a, 41-500 Chorzów, Poland.
  • Jachowicz R; Faculty of Science and Technology, Institute of Physics and SMCEBI, University of Silesia, 75 Pulku Piechoty 1a, 41-500 Chorzów, Poland.
Pharmaceutics ; 13(2)2021 Jan 23.
Article em En | MEDLINE | ID: mdl-33498609
ABSTRACT
Amorphization serves as a strategy for the improvement of poor dissolution characteristics of many drug compounds. However, in many formulations the content of polymeric stabilizer is high, which is undesirable from the perspective of future applications. Thus, studying the composition-dependent stability of amorphous solid dispersions seems to be demanded. In this paper, we describe the amorphization of ezetimibe, a lipid-lowering drug, in the spray drying process and investigate the effect of polyvinylpyrrolidone-co-poly(vinyl acetate) (PVP/VA) content on the physical stability and dissolution characteristics of the drug. Fully amorphous systems were obtained when the concentration of the polymer in solid dispersion was as low as 20%. The amorphization led to the dissolution enhancement by even 70%, with a noticeable sudden increase at around 40% of PVP/VA content and very small variations for systems having 66-90% PVP/VA. It was also correlated to wettability characteristics of solid dispersions, which may suggest that in the vicinity of 40% of the polymer content, the behavior of the system becomes independent of the PVP/VA content.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article